Agios CSO Bruce Car resigns, signs consulting agreement through March 2023

AGIOS PHARMACEUTICALS, INC.

Dr. Bruce Car steps down as chief scientific officer effective August 1, 2022.
Consulting agreement runs from August 1, 2022 to March 31, 2023, extendable with consent.
Services limited to transition and research science support, not exceeding 10 hours per week.
Outstanding equity awards will continue to vest during the consulting term.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bruce Car

Chief Scientific Officer

AGIO · AGIOS PHARMACEUTICALS, INC.

Effective: 2022-08-01
Filed: May 26, 2022, 7:59 PM ET

the effective date of Dr. Car’s resignation as the Company’s chief scientific officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Car resigned as Chief Scientific Officer at AGIOS PHARMACEUTICALS, INC..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

the effective date of Dr. Car’s resignation as the Company’s chief scientific officer

View on SEC.gov

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-160979

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.